Lidocaine Hydrochloride Injection, Solution
Product Images NDC 55150-253

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 55150-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg / mL))

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg / mL))
This is a description of DICS AUROME 1% which is an injection solution for infiltration and nerve block. It comes in a 10 mL vial and contains 100 mg of medication per 10 mL. It is only available by prescription and must be stored at a controlled room temperature. The manufacturer is AuroMedics Pharma LLC and the product is distributed by a company located in Windsor, NJ. The solution contains methylparaben as a preservative and lidocaine, which may cause discoloration or have a 2% HCl injection USP precipitate. It is not suitable for caudal or epidural use, and is sterilized by autoclaving. The product is made in India and has a code of SORUSS/IY2010.*
FDA Label Image

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg / mL))

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg / mL))
This text appears to be a mix of letters, numbers, symbols, and miscellaneous words/phrases; therefore, it is not available.*
FDA Label Image

Package Label-principal Display Panel (2% 1,000 mg per 50 mL (20 mg / mL))

Package Label-principal Display Panel (2% 1,000 mg per 50 mL (20 mg / mL))
This is a description of a pharmaceutical product with the NDC code 55150-256-50, which is sterile and non-pyrogenic. It contains Lidocaine Hydrochloride Injection, USP and Methylparaben as a preservative. It is indicated for infiltration and nerve block but not for caudal or epidural use. The solution should not be used if it appears discolored or contains a precipitate. It is distributed by AuroMedics Pharma LLC and comes in a 50mL multiple-dose vial. The product should be stored at 20-25°C according to USP Controlled Room Temperature guidelines. The information on the label is also mostly in English.*
FDA Label Image

Package Label-principal Display Panel (2% 1,000 mg per 50 mL (20 mg / mL))

Package Label-principal Display Panel (2% 1,000 mg per 50 mL (20 mg / mL))
This is a description of a Lidocaine Hydrochloride Injection, marked with NDC code 55150-256-50. Each milliliter of the solution contains 20mg of Lidocaine hydrochloride, 6mg of Sodium chloride, and 1mg of Methylparaben. The injection should not be used if the solution is discolored or contains a precipitate. It is recommended to consult the package insert for dosage and full prescribing information before use. The vial stopper is not made with natural rubber latex. The solution is distributed by Romedic and manufactured by AuroMedics Pharma LLC in India. The item is provided in a sterile, 25x 50mL vial, and is intended for infiltration and nerve block use only (not for caudal or epidural use).*
FDA Label Image

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg / mL))

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg / mL))
This is a description of 1% Lidocaine hydrochloride injection solution. It is intended for nerve block and infiltration only, and not for use in caudal or epidural procedures. The solution is available in a 10mL presentation, containing 100 mg of Lidocaine hydrochloride per mL. The solution also includes Sodium Chloride, Methylparaben and Sodium hydroxide and/or hydrochloric acid to adjust pH. Each mL has 10 mg of Lidocaine hydrochloride, which is equivalent to 8.65 mg of Lidocaine. This medicine should not be used if the solution is discolored or has a precipitate. It is stored at 20° to 25°C (68° to 77°F) and may be re-sterilized by autoclaving.*
FDA Label Image

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg / mL))

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg / mL))
This is a description of a lidocaine HCl Injection, USP, with a concentration of 1%. It is nonpyrogenic and contains methylparaben as a preservative. It is supplied in a 20 mL multiple-dose vial and is for use in infiltration and nerve blocks, but not for caudal or epidural use. It can be resterilized by autoclaving and should not be used if the solution is discolored or contains a precipitate. The product should be stored at 20° to 25°C (68° to 77°F) and distributed by pyroMedics Pharma LLC. The product is made in India and the Gode number is TS/DRUGS/132010.*
FDA Label Image

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg / mL))

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg / mL))
This is a medication containing lidocaine HCI injection for infiltration and nerve block. It is not for caudal or epidural use. The solution has a preservative of methylparaben and comes in a non-pyrogenic multiple dose vial. The usual dosage should be consulted in the package insert, and the solution can be resterilized by autoclaving. The medication contains sodium chloride and sodium hydroxide and/or hydrochloric acid to adjust pH approx. 6.5 (5.0 to 7.0).*
FDA Label Image

Package Label-principal Display Panel (1% 500 mg per 50 mL (10 mg / mL))

Package Label-principal Display Panel (1% 500 mg per 50 mL (10 mg / mL))
This is a description for a pharmaceutical product, specifically a 50 mL multiple dose vial of Lidocaine Ceneresteilizabyaoiaving with a concentration of 10mg per mL (500mg per 50 mL). The product is sterile and nonpyrogenic, containing a preservative called Methylparaben. It is intended for use in infiltration and nerve block, but not for caudal or epidural use. The solution should not be used if it appears discolored or contains a precipitate. The product should be stored within a temperature range of 20° to 25°C (68° to 77°F) and distributed by AuroMedics Pharma LLC, a company based in India. However, some parts of the text are not legible due to errors.*
FDA Label Image

Package Label-principal Display Panel (1% 500 mg per 50 mL (10 mg / mL))

Package Label-principal Display Panel (1% 500 mg per 50 mL (10 mg / mL))
This is a description of a sterile injection called 2S DIC AUROME, containing 1% Lidocaine in 0 Hcl Injection, USP with 500 mg per 50 mL (10mg/mL). It is used for infiltration and nerve block but not for caudal or epidural use. The injection also contains Methylparaben as a preservative, Lidocaine hydrochloride USP, Sodium chloride and Sodium hydroxide and/or hydrochloric acid to adjust pH. Its usual dosage can be found in the package insert. It is sterilized and can be resterilized by autodaving. The solution should not be used if it appears discolored or contains precipitates. It can be stored in a controlled room temperature of 20° to 25°C (68°F to 77°F). The vial stopper is not made with natural rubber latex. It is distributed in the USA by AuroMedics Pharma LLC and made in India.*
FDA Label Image

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg / mL))

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg / mL))
This is a medication called DICS AUROME. It is available in a 10 mL multiple dose vial, and contains 200 mg per 10 mL (with a concentration of 20 g/mL). It is used specifically for infiltration and nerve block, and is not meant for caudal or epidural use. It is sterile, nonpyrogenic, and has Methylparaben as a preservative. It can be resterilized by autoclaving. Users should not use the medication if the solution is discolored or contains precipitate. It should be stored at 20° to 25°C (68° to 77°F) and is distributed by AuroMedics Pharma LLC.*
FDA Label Image

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg / mL))

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg / mL))
This is a description of a drug called Lidocaine Injection, which is used for Infiltration and Nerve Block. It should not be used for Caudal or Epidural Use. It contains Lidocaine hydrochloride USP 20mg, Sodium chloride 6 mg HCI Injection, USP, and Vetryparaoen 1 mg. The dosage information is provided in the package insert, and it is recommended to consult a healthcare professional for more information. The drug is manufactured by AuroMedis Prarma LLC in India. The code is TS/DRUGS/13/2010.*
FDA Label Image

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg / mL))

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg / mL))
This is a description of a pharmaceutical product with the National Drug Code 55150-255-20. It is a sterile solution that can be autoclaved and contains methylparaben as a preservative. It is intended for infiltration and nerve block use, but not for caudal or epidural use. The solution should not be used if it appears discolored or contains any sediment. It is manufactured in India by RuroMaics Parma LG and distributed from New Jersey.*
FDA Label Image

Lidocaine Hydrochloride Chemical Structure (Lidocaine Str)

Lidocaine Hydrochloride Chemical Structure (Lidocaine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.